Our Research & Technology division partners with innovator companies in pharmaceuticals and animal health to develop new molecules or extend the lifecycle of existing molecules, and develops exclusive products for global clients. Our experienced team develops innovative, cost-effective and safe processes for molecules that go off patent and explores long-term products. Several products developed in-house have gone from lab scale to kilogram scale to pilot scale / validation scale to commercialization.
Hikal has a successful track record of delivering active pharmaceutical ingredients (APIs) and intermediates to global clients. Our facilities are built to meet the specific needs of clients and stringent requirements of the United States, European, and Japanese markets.
Our manufacturing facilities adopt new and emerging technologies to ensure smooth transfer of research and technology from the client to the plant and commercialization of processes. Our analytical equipment complies with global regulatory standards.
Our plants have USFDA, PMDA, EU GMP, TGA approved facilities and adopt ICH Q7 and ISO 9001 quality standards. Hikal is a signatory of Responsible Care®, ISO 14001 and OHSAS 18001. Our comprehensive environment, health and safety (EHS) policy ensures that the interests of all constituents are safeguarded.
Our research & technology capabilities blend expertise in chemistry with advanced facilities.
|Lab for high potency products(OEL levels to 10 µg/m3)||1|
|Process intensification lab||1|
|Kilo lab||2 (including 1 cGMP kilo lab)|
|High pressure lab||1|
|Solid state lab||1|
|Particle size engineering lab||1|
Hikal’s cGMP kilo lab in Pune allows scale-up of processes at our R&T labs and transfer of technology from global clients using advanced facilities:
Hikal’s advanced flow reactor has a capacity of 1 MT per month with a dedicated mixing module for multiphase systems (liquid gas, immiscible liquids) and an on-demand pilot scale capability:
Hikal’s pinch tube reactor has a capacity of 5T per month with a scale-up capability of 100 kg per month:
Hikal’s fixed bed vapor reactor has an annual capacity of 1,000 MT: